All lobbying filings

SIEMENS MEDICAL SOLUTIONS USA, INC

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $550,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 16

S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
S 1399
Health Tech Investment Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
S 1410
Find It Early Act
HR 4417
Mobile Cancer Screening Act
S 2927
Mobile Cancer Screening Act
HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
S 2882
Continuing Appropriations and Extensions and Other Matters Act, 2026
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
HR 2385
CREATE AI Act of 2025
S 2750
SANDBOX Act

Lobbying activity 9

Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled medical devices; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy, transparency and cybersecurity.

Medicare/Medicaid

S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.

Budget/Appropriations

H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.

Trade (domestic/foreign)

Issues related to medical supply chains and procurement; and Issues related to international trade.

Tariff (miscellaneous tariff bills)

Issues related to tariffs and supply chain resilience; and Issues related to tariffs on medical devices.

Defense

H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.

Medical/Disease Research/Clinical Labs

Issues related to NIH funding; and Issues related to ARPA-H Funding.

Natural Resources

Issues related to critical minerals supply chains and production.

Science/Technology

H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.